Abstract:Background Biliary atresia (BA) is a severe liver disease in neonates, which is caused by obliteration of the intra- and the extrahepatic biliary duct leading to cholestasis, and progressive liver injury and fibrosis. Epithelial-mesenchymal transformation (EMT) of bile duct epithelial cells is considered to be a key mechanism in the pathogenesis of liver fibrosis. The present study aimed to explore the role and underlying mechanism of ferroptosis in EMT and liver fibrosis. Methods Thirty-four cases of BA liver tissue and twenty-two cases of adjacent normal liver tissue from hepatoblastoma were subjected to RNA-sequencing and proteomic analysis to verify the expression differences of EMT and fibrosis between BA and non-BA liver tissues, as well as the correlation between the expression level of the differential gene SFXN3 in BA and clinical pathological characteristics. A mouse liver model of biliary atresia induced by rotavirus in rhesus monkeys was constructed to verify the expression differences of EMT and fibrosis-related genes. A fibrosis model was constructed by inducing cholangiocytes with TGF-β, and the effects of SFXN3 knockdown and overexpression on cellular ferroptosis, EMT, and fibrosis were studied. Results We found that EMT-related molecules were significantly upregulated in BA patients. In addition, RT-PCR and Western blot experiments on liver of BA mice also revealed significant activation of fibrosis and EMT-related molecules In terms of mechanism, we found that SFXN3 was significantly upregulated in the fibrotic liver of patients (IDDF2024-ABS-0285 Figure 1). And it is positively correlated with the degree of fibrosis, EMT and clinical assay index. We discovered through colocalization that SFXN3 is localized to the biliary epithelial cells (IDDF2024-ABS-0285 Figure 2). Mechanically, we found that nuclear receptor coactivator NCOA4, a master regulator of ferritin phagocytosis, significantly activates and degrades ferritin during EMT, thereby releasing large amounts of ferrous, further leading to SFXN3-dependent mitochondrial iron overload. Conversely, knockdown of NCOA4 or SFXN3 with small interfering RNAs could effectively ameliorate ferroptotic cell death, cellular or mitochondrial iron overload and lipid peroxides accumulation (IDDF2024-ABS-0285 Figure 3). Conclusions Overall, our findings underscore that ferritinophagy activation and SFXN3-dependent mitochondrial iron overload play critical roles in ferroptosis and EMT in biliary atresia.

Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Single‐cell and spatial transcriptomics reveal the fibrosis‐related immune landscape of biliary atresia

MicroRNA-21/PTEN/Akt Axis in the Fibrogenesis of Biliary Atresia

Animal and organoid models to elucidate the anti-fibrotic effect of steroid on biliary atresia

YAP Activation and Implications in Patients and a Mouse Model of Biliary Atresia

LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia

IDDF2024-ABS-0285 Ferritinophagy Activation and Sideroflexin3-Dependent Mitochondrial Iron Overload Contribute to Biliary Epithelial Cells Epithelial-Mesenchymal Transition and Liver Fibrosis in Biliary Atresia

Progress in Biomarkers Related to Biliary Atresia

Mir-222 Overexpression May Contribute to Liver Fibrosis in Biliary Atresia by Targeting Ppp2r2a

Biglycan promotes hepatic fibrosis through activating heat shock protein 47

Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia

Immunologic Regulations in the Pathogenesis of Biliary Atresia and Hepatic Fibrosis

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis

Serum TGF-β1 and VEGF Levels Reflect the Liver Hardness and Function in Children with Biliary Atresia

CircUTRN24/miR-483-3p/IGF-1 Regulates Autophagy Mediated Liver Fibrosis in Biliary Atresia

New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets

Hepatocyte Growth Factor Attenuates Liver Fibrosis Induced by Bile Duct Ligation.

Forkhead Box A3 Attenuated the Progression of Fibrosis in A Rat Model of Biliary Atresia

Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia

Fibroblast‐specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology